Catalog | Name | Composition | Particle size | Specifications | Storage condition | Shelf life | Application | Description |
NZs-1 | Cal-Cs/PEG/Ag | Cr6+, carbon spheres, poly(ethylene glycol), Ag | 300-500 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Ion visual sensing | Cr6+ can not only adjusted the electronic structure of Ag atoms but also improved the geometric structure of the adsorbed intermediate, which resulted in the optimization of free energy and change of bond lengths in the catalytic reaction process, increasing the POD-like activity of Cal-CS/PEG/Ag. |
NZs-2 | Porous Co3O4
nanosheets | Co3O4 | 500 nm-1.60 μm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Environmental detection | Porous Co3O4 nanosheets exhibit excellent visual colorimetric detection performance. |
NZs-3 | MnPc | Phthalocyanine, Mn | 50-200 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | Self-assembled manganese phthalocyanine (MnPc) nanoparticles exhibit shape-dependent POD-like catalytic activities. |
NZs-4 | Ru@PVP | Ru, polyvinyl pyrrolidone | 2.9-3.4 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Highly sensitive detection of tumor markers | Polyvinyl pyrrolidone (PVP) modified Ru nanozyme exhibits extremely high POD‐like specific activity. |
NZs-5 | Ru@PVA | Ru, polyvinyl alcohol | 2.9-3.4 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Highly sensitive detection of tumor markers | Polyvinyl alcohol (PVA) modified Ru nanozyme exhibits extremely high POD‐like specific activity. |
NZs-6 | Ru@PAA | Ru, polyacrylic acid | 2.9-3.4 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Highly sensitive detection of tumor markers | Polyacrylic acid (PAA) modified Ru nanozyme exhibits extremely high POD‐like specific activity. |
NZs-7 | 2D cobalt hydroxide oxide
nanosheets | Co | 50-70 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Inhibit inflammation | 2D cobalt hydroxide oxide nanosheets exhibit superior reactive oxygen species (ROS) scavenging properties and can protect cells from oxidative damage. |
NZs-8 | Hemin@BSA@ZIF-8 | Hemin, bovine serum albumin (BSA), zeolitic imidazolate framework-8 (ZIF-8) | 200-300 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Biosensing | The structure of Hemin@BSA@ZIF-8 is similar to horseradish peroxidase (HRP), in which hemin served as the active cofactor surrounded by BSA as a blocking pocket to construct a favorable hydrophobic space for substrate enrichment. Benefiting from the confinement effect, ZIF-8 with a porous intracavity was regarded as the ideal outer layer for Hemin@BSA@ZIF-8 to accelerate substrate transport and significantly enhance its POD-like activity. |
NZs-9 | Hemin@Ftn | Hemin, ferritin (Ftn) | 20-30 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Biosensing | Hemin@Ftn possesses high POD catalytic activity and high tolerance to the harsh environmental conditions, such as high temperature and chemical denaturant. This protein-based nanozyme bridges the gap between natural enzymes and nanomaterial-based nanozymes by the incorporation of a catalytically active prosthetic group into a highly stable Ftn. |
NZs-10 | Ru@PSS | Ru, polystyrene sulfonate | 2.9-3.4 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Highly sensitive detection of tumor markers | Polystyrene sulfonate (PSS) modified Ru nanozyme exhibits a POD‐like specific activity of up to 2820 U·mg−1. |
NZs-11 | CDs@NC | ZIF-8 filled with glucose (G@ZIF-8) | 20-30 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Detection of gastric cancer relevant D-amino acids | The carbon dots confined in N-doped carbon (CDs@NC) can readily act as POD-like nanozyme, and its POD-like activity can be tuned easily by adjusting the content of glucose precursors. |
NZs-12 | FexNiy-MOF | Fe, Ni | 1 μm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Biosensing | The introduction of Ni improves the conversion efficiency between Fe3+ and Fe2+, promotes the generation of hydroxyl radicals, and thereby enhances the POD activity of FexNiy-MOF. |
NZs-13 | Cu/CN | Cu, carbon nitride (CN) | 2-10 μm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Colorimetric sensors | Due to its ultrathin nanosheet structure and high density of Cu active sites, with a Cu loading of up to 14.3 wt%, carbon nitride-supported Cu single-atom nanozyme (Cu/CN) exhibits POD-like activity and excellent catalytic performance. |
NZs-14 | Fe1Co1-NC | Fe, Co, N, C | 200-1000 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Inhibit tumor growth | The Co atom site can cooperatively affect the d-band center position of the Fe atom site and serve as the second reaction center, which makes Fe1Co1-NC nanozyme have better POD-like activity. |
NZs-15 | MoSA-Nx-C | Mo, N, C | 30-50 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Biosensing | MoSA-Nx-C single-atom nanozyme has superior and exclusive POD-like activity, and the POD-like specificity is well regulated by the coordination numbers of single Mo sites. |
NZs-16 | d-CoFe-LDHs | Co, Fe | 100-1000 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Detection of ascorbic acid | Defect-rich CoFe-layered double hydroxides (d-CoFe-LDHs) nanosheets have lower H2O2 adsorption energy, which promotes the decomposition of H2O2, thereby effectively enhancing the POD-like activity. |
NZs-17 | FeBNC SAzymes | Fe, B, N, C | 100-1000 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Detection of enzyme activity and
small molecule | Boron-induced charge transfer effects can adjust the positive charge of the central Fe atom to reduce the energy barrier of the formation of hydroxyl radical, thereby boosting the POD-like activity of FeBNC single atom nanozyme (SAzymes). |
NZs-18 | IrOx-GOD | Iridium oxide (IrOx), glucose oxidase (GOD) | 20-50 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Regulating glucose or reactive oxygen species metabolism in tumors | IrOx-GOD can convert the over-expressed H2O2 at tumor tissue to O2, and O2 could further react with continuous supplied glucose to produce gluconic acid and H2O2 by GOD, achieving continuous supply of O2 and H2O2. |
NZs-19 | Au@HCN | Au, carbon shell | 50-100 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | Au@HCNs have a typical yolkdshell structure in which an Au nanoparticle core is encapsulated within a hollow carbon nanospheres with porous shell. The Au@HCNs perform high POD-like and oxidased-like activity enzyme functions due to the cooperative effect of Au nanoparticles and the carbon shell in the yolkdshell structure. |
NZs-20 | Cu2-xTe | Au, carbon shell | 50-100 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | Cu2-xTe nanoparticles exhibit tunable enzyme-mimic activity including POD and glutathione oxidase under near-infrared-II (NIR-II) light. |
NZs-21 | Ir-N5 SA | Ir, N | 50-100 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | Ir-N5 SA is a single-atom nanozyme composed of a single iridium atom and five nitrogen atoms and has a variety of enzyme-like catalytic activities including POD-like, catalase (CAT)-like, oxidase-like and NADH oxidase (NOX)-like activities. |
NZs-22 | BiO2-x nanosheets | BiO2-x | 100-250 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Piezocatalytic, sonothermal, and enzymatic therapies | BiO2-x nanosheets exhibit POD-like and CAT-like activities. The oxygen vacancies generated in BiO2-x nanosheets are beneficial to the adsorption of H2O2 and increase the carrier density for the production of ROS. In addition, BiO2-x nanosheets also have excellent acoustic and thermal effects. |
NZs-23 | AuPtCo nanozymes | Au, Pt, Co | 100-200 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Glow-type chemilumines-cence bioanalysis | Taking advantage of the good charge transfer and synergistic effects between gold, platinum, and cobalt elements, AuPtCo nanozymes exhibit strong catalytic activity. AuPtCo nanozymes can catalyze the Chemiluminescence (CL) emission in a flash type after reacting with the substrate N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) and the oxidant H2O2. |
NZs-24 | Fe3O4@Pt@E5 | Fe3O4, Pt, E5 | 10-50 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Acute myeloid leukemia treatment | Fe3O4@Pt@E5 exhibit POD-like, CAT-like and oxidase activities. It has uniform morphology and small size, and has good stability and biocompatibility. |
NZs-25 | Prussian blue nanozymes | Fe4[Fe(CN)6]3, KFe[Fe(CN)6] | about 200 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antioxidant and anti-inflammatory materials, etc. | Prussian blue nanozymes can effectively scavenge ROS via multi-enzyme activities including POD-like activity, CAT-like activity and superoxide dismutase (SOD)-like activity. Prussian blue nanozymes can be used as new antioxidant and anti-inflammatory materials, and can also be used in the fields such as drug loading, photothermal therapy, etc. |
NZs-26 | Fe3O4 nanozymes | Fe3O4 | 200 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Promote stroke
healing | Fe3O4 nanozymes exhibit triple enzyme-like activities including POD, CAT, and SOD, thus potentially possessing the ability to regulate the ROS level. |
NZs-27 | SiO2@MPGs | SiO2 nanoparticles, metal coordinated polymeric nanogels (MPGs) | —— | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Bioresponsive fluorescence imaging | SiO2@MPGs exhibit POD and SOD activities. Their thermal stability is better than molecular enzyme mimics and natural horseradish peroxidase (HRP). |
NZs-28 | CoMo hybrids | Co(OH)2, MoSx | 5 μm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Colorimetric detection | The CoMo hybrids exhibit triple enzyme-like activities including POD-, CAT- and oxidase-like activities. In addition, the CoMo hybrids is also reproducible, stable and reusable, that is, after 10-cycle uses, >90% mimic enzyme activity of the CoMo hybrids is still maintained. |
NZs-29 | 2D Cu-TCPP(Fe)/GOD | Cu, tetra(4-carboxyphenyl)porphine (TCPP) | 2-5 μm | 50 mg | -4 ℃ | 6 months in sealed condition | Antibacterial | 2D Cu-TCPP(Fe)/GOD have good catalytic performance. Among them, GOD can effectively convert the glucose into abundant gluconic acid to self-activate the POD-like activity of the nanosheets, and meanwhile the considerable amount of generated H2O2 can be used for the subsequent catalysis of the nanosheets. |
NZs-30 | MOF-Au-Ce | Au, Ce | 500 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antibacterial | MOF-Au-Ce have dual enzyme-like activities. On the one hand, the MOF doped with Au (MOF-2.5Au) showed enhanced POD-mimetic activity, which was potent for antibacteria. On the other hand, the Ce complexes grafted to MOF revealed admirable DNase-mimetic activity to catalyze hydrolysis of eDNA. |
NZs-31 | R-CMs | Cu, MoS2 | diameter of about 300 nm
, length of about 10 μm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antibacterial | R-CMs are a series of defect-rich adhesive nanozymes that have inherent bacterial capturing and efficient antibacterial characteristics. With abundant rough surfaces formation and defect-rich edge sites exposure, they could fast trap bacteria within the scope of elevated ROS destruction. |
NZs-32 | MoS2 nanozymes | MoS2 | 200-300 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antibacterial | MoS2 nanozymes possess both intrinsic POD-like activity and highly photothermal conversion efficiency in the NIR region. They covalently linked to hydrogel can achieve synergistic antibacterial effects. |
NZs-33 | ZIF | ZIF, Co | 100-200 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | The ZIF is a flower-like nanozyme with highly permeable leaflets accommodating catalytic metal sites. The cobalt single-atom/cluster sites in its highly porous matrix generated POD/oxidase-like activities with high catalytic efficiency up to 6 orders of magnitude greater than that of conventional nanozyme/biozymes. |
NZs-34 | DMSN/Fe3O4-Mn@CB-839(DFMC) | Dendritic mesoporous silica nanoparticles (DMSNs), Fe3O4, Mn, Telaglenastat CB-839 | 100-200 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | DFMC exhibits POD-like activity under acidic conditions, catalyzing the decomposition of H2O2 into hydroxyl radicals. This process also promotes the formation of lipid peroxides. In addition, the nanozyme can also effectively consume glutathione (GSH), thereby enhancing ROS-mediated tumor catalytic therapy. |
NZs-35 | CDs@ZIF-8 | CDs, ZIF-8 | 500 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Colorimetric detection of H2O2 and GSH | The ZIF-8 matrix protects the carbon dots (CDs) from aggregation and quenching, and the synergistic effect of CDs and ZIF-8 promotes electron transfer, giving the CDs@ZIF-8 excellent POD-like activity. |
NZs-36 | PCF-a NEs | Pd, Cu, Fe | 5 nm | 50 mg | -4 ℃ | 6 months in sealed condition | Promote tumor ablation | PCF-a NEs exhibite a cascade POD and glutathione peroxidase mimicking activities in circumneutral pH. PCF-a NEs exhibit photothermally augmented POD property and high photothermal conversion efficiency (62%) for synergistic tumor cell apoptosis. |
NZs-37 | GOD/hemin/DHA@ZIF-8 | glucose oxidase (GOD), hemin, dihydroartemisinin (DHA), ZIF-8 | 100 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | GOD/hemin/DHA@ZIF-8 exhibit POD-like, GOD, glutathione peroxidase (GPx)-like activities. SufficientH2O2 was supplied in time via GOD-mediated glycolysis, which sustained the generation process of toxic hydroxyl radicals. Moreover, hemin (Fe3+) acted as not only peroxidase producing hydroxyl radicals, but also GPx consuming antioxidant GSH. |
NZs-38 | Pyrite nanozymes | FeS2 | 200 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Antitumor | The highly active pyrite nanozymes overcome the problem of low affinity of traditional peroxide nanozymes for H2O2 and can catalyze limited H2O2 in tumor sites to generate a large amount of hydroxyl radicals. At the same time, the glutathione oxidase activity of pyrite nanozymes, not only provides substrate H2O2 for their POD activity, but also catalyzes the oxidation of GSH, causing cellular iron death, thereby achieving apoptosis-ferroptosis synergistic treatment of tumors. Importantly, the pyrite nanozymes can achieve efficient and safe tumor treatment effects as a single material without any other help, indicating that it has great potential for clinical translation. |
NZs-39 | BSA@AuNCs | BSA, AuNCs | 5 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Nanosensor CL probe | BSA@AuNCs have intrinsic POD-mimetic effect, and based on the inhibition of their POD-mimetic effect, nanosensor chemiluminescent (CL) probe for sensing GSH can be developed. |
NZs-40 | RuO2 NPs | RuO2 | 5 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Prevention of acute kidney injury | RuO2 NPs catalytic properties mimic the activity of POD, CAT, SOD and GPx. In addition, RuO2 NPs show excellent antioxidant activity and low biological toxicity. And the nanozyme can be efficiently and rapidly absorbed by human embryonic kidney cells while significantly reducing ROS-induced apoptosis by eliminating excess ROS. |
NZs-41 | Cu-HCF | Cu, Fe | 100 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Tumor-specific
amplified cascade enzymatic therapy | Copper hexacyanoferrate (Cu-HCF) nanozyme possesses active single-site copper and exhibits cascade enzymatic activity (i.e., POD and glutathione oxidase) within tumor microenvironment. |
NZs-42 | Cu1.5Mn1.5O4 CFNSs | Cu, Mn | 500 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Bacterial-infected wound therapy | Cu1.5Mn1.5O4 CFNSs exhibit enhanced triple enzyme activities, namely POD, oxidase and GPx, which can significantly enhance the production of ROS and effectively kill bacteria. In addition, Cu1.5Mn1.5O4 CFNSs also exhibit excellent biosafety. |
NZs-43 | PEG/Ce-Bi@DMSN | CeO2, Bi2S3, dendritic mesoporous
silica nanoparticles (DMSN), PEG | 100 nm | 50 mg
100 mg | -4 ℃ | 6 months in sealed condition | Tumor nanocatalytic therapy | PEG/Ce-Bi@DMSN exhibit dual enzymemimic catalytic activities (i.e., POD- and CAT-mimic activities) under acidic conditions that can regulate the tumor microenvironment, that is, simultaneously elevate oxidative stress and relieve hypoxia. In addition, the nanozymes can effectively consume the overexpressed GSH through redox reaction. |